These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 29654885

  • 1. Fabrication of inhaled hybrid silver/ciprofloxacin nanoparticles with synergetic effect against Pseudomonas aeruginosa.
    Al-Obaidi H, Kalgudi R, Zariwala MG.
    Eur J Pharm Biopharm; 2018 Jul; 128():27-35. PubMed ID: 29654885
    [Abstract] [Full Text] [Related]

  • 2. Generation of High Dose Inhalable Effervescent Dispersions against Pseudomonas aeruginosa Biofilms.
    Mohammed A, Zurek J, Madueke S, Al-Kassimy H, Yaqoob M, Houacine C, Ferraz A, Kalgudi R, Zariwala MG, Hawkins N, Al-Obaidi H.
    Pharm Res; 2020 Jul 19; 37(8):150. PubMed ID: 32686026
    [Abstract] [Full Text] [Related]

  • 3. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ, Briales A, Brochmann RP, Wang H, Kragh KN, Kolpen M, Hempel C, Bjarnsholt T, Høiby N, Ciofu O.
    Pathog Dis; 2014 Apr 19; 70(3):440-3. PubMed ID: 24376174
    [Abstract] [Full Text] [Related]

  • 4. Silver nanoparticle with potential antimicrobial and antibiofilm efficiency against multiple drug resistant, extensive drug resistant Pseudomonas aeruginosa clinical isolates.
    Kamer AMA, El Maghraby GM, Shafik MM, Al-Madboly LA.
    BMC Microbiol; 2024 Jul 26; 24(1):277. PubMed ID: 39060955
    [Abstract] [Full Text] [Related]

  • 5. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
    Patel KK, Tripathi M, Pandey N, Agrawal AK, Gade S, Anjum MM, Tilak R, Singh S.
    Int J Pharm; 2019 May 30; 563():30-42. PubMed ID: 30926526
    [Abstract] [Full Text] [Related]

  • 6. Delafloxacin--A novel fluoroquinolone for the treatment of ciprofloxacin-resistant Pseudomonas aeruginosa in patients with cystic fibrosis.
    Millar BC, McCaughan J, Rendall JC, Moore JE.
    Clin Respir J; 2021 Jan 30; 15(1):116-120. PubMed ID: 32790958
    [Abstract] [Full Text] [Related]

  • 7. Sodium Nitrite Inhibits Killing of Pseudomonas aeruginosa Biofilms by Ciprofloxacin.
    Zemke AC, Kocak BR, Bomberger JM.
    Antimicrob Agents Chemother; 2017 Jan 30; 61(1):. PubMed ID: 27799207
    [Abstract] [Full Text] [Related]

  • 8. In vitro prevention of Pseudomonas aeruginosa early biofilm formation with antibiotics used in cystic fibrosis patients.
    Fernández-Olmos A, García-Castillo M, Maiz L, Lamas A, Baquero F, Cantón R.
    Int J Antimicrob Agents; 2012 Aug 30; 40(2):173-6. PubMed ID: 22727530
    [Abstract] [Full Text] [Related]

  • 9. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
    Chang RYK, Das T, Manos J, Kutter E, Morales S, Chan HK.
    AAPS J; 2019 Apr 04; 21(3):49. PubMed ID: 30949776
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2017 Nov 04; 61(11):. PubMed ID: 28848007
    [Abstract] [Full Text] [Related]

  • 11. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
    Loo CY, Lee WH, Lauretani G, Scalia S, Cipolla D, Traini D, Young P, Ong HX.
    Pharm Res; 2018 Feb 07; 35(3):50. PubMed ID: 29417313
    [Abstract] [Full Text] [Related]

  • 12. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H, Chhibber S, Harjai K.
    Int J Antimicrob Agents; 2015 Apr 07; 45(4):359-67. PubMed ID: 25604277
    [Abstract] [Full Text] [Related]

  • 13. Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study.
    Derbali RM, Aoun V, Moussa G, Frei G, Tehrani SF, Del'Orto JC, Hildgen P, Roullin VG, Chain JL.
    Mol Pharm; 2019 May 06; 16(5):1906-1916. PubMed ID: 30900903
    [Abstract] [Full Text] [Related]

  • 14. Fostering Innovation in the Treatment of Chronic Polymicrobial Cystic Fibrosis-Associated Infections Exploring Aspartic Acid and Succinic Acid as Ciprofloxacin Adjuvants.
    Silva E, Monteiro R, Grainha T, Alves D, Pereira MO, Sousa AM.
    Front Cell Infect Microbiol; 2020 May 06; 10():441. PubMed ID: 32974221
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W, Noreddin A.
    Microb Drug Resist; 2014 Dec 06; 20(6):575-82. PubMed ID: 25050970
    [Abstract] [Full Text] [Related]

  • 16. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR, Gonda I, Dahms J, Cipolla D, Davis AM, Chalmers JD, Froehlich J.
    Clin Microbiol Infect; 2019 Dec 06; 25(12):1532-1538. PubMed ID: 31035017
    [Abstract] [Full Text] [Related]

  • 17. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 18. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.
    Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2014 Oct 28; 58(10):5818-30. PubMed ID: 25049240
    [Abstract] [Full Text] [Related]

  • 19. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M, del Campo R, Baquero F, Morosini MI, Turrientes MC, Zamora J, Cantón R.
    Clin Microbiol Infect; 2011 May 28; 17(5):704-11. PubMed ID: 20673272
    [Abstract] [Full Text] [Related]

  • 20. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT, Sun SP, Chan JG, Wang P, Barraud N, Rice SA, Wang J, Li J, Chan HK.
    Mol Pharm; 2015 Aug 03; 12(8):2594-603. PubMed ID: 25423590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.